Clinical Trials Directory

Trials / Completed

CompletedNCT01928212

Retinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-analysis

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Yifan Feng · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Optical coherence tomography (OCT) is a non-invasive retinal imaging technology that can provide high-resolution cross-sectional images of the peripapillary retinal nerve fiber layer (RNFL) and measure its thickness. A reduction of the RNFL thickness has been detected in several neurodegenerative diseases, such as multiple sclerosis, CADASIL and Alzheimer's disease. Different studies have reported RNFL changes also in Parkinson's disease (PD),a common neurodegenerative disease characterized by motor dysfunctions, originally described by James Parkinson in 1817. PD is characterized by selective dopaminergic neuronal cells loss, which may correlate with RNFL thinning. Previous studies on this subject, however, reported contradicting results. Some investigations reported reductions of the RNFL thickness while others did not. In the present study, in order to determine whether RNFL thickness is reduced in PD patients, we performed a meta-analysis and systematically evaluated RNFL thickness measurements with OCT in a series of PD patients and in the healthy control groups.

Conditions

Interventions

TypeNameDescription
DEVICEOptical coherence tomography

Timeline

Start date
2013-08-01
Primary completion
2014-01-01
Completion
2014-05-01
First posted
2013-08-23
Last updated
2014-07-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01928212. Inclusion in this directory is not an endorsement.